BROADCASTS.com

Every week, The American Journal of Managed Care\xae recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.\n\nThis week, the top managed care stories included\xa0Sanofi offering a deal to payers for its cholesterol drug; a\xa0\u201cright-to-try\u201d bill is defeated in the House; and a forum of oncology pharmacists discusses \u201chealth insurance\u201d versus \u201chealthcare.\u201d\n\nRead more about the stories in this podcast:\nWith ODYSSEY Results in Hand, Talks With Payers Begin to Jump Start Praluent Sales: www.ajmc.com/conferences/acc-2018/with-odyssey-results-in-hand-talks-with-payers-begin-to-jump-start-praluent-sales\n"Right-to-Try" Legislation Defeated in House Amid Doubts About Its Necessity: www.ajmc.com/newsroom/right-to-try-legislation-headed-for-a-vote-as-doubts-about-its-necessity-remain\nCoverage of the American College of Cardiology\u2019s 67th Annual Scientific Session & Expo: www.ajmc.com/conferences/acc-2018\nRep. Doug Collins: Providing Healthcare vs Health Insurance: www.ajmc.com/conferences/ncoda-spring-forum-2018/rep-doug-collins-providing-healthcare-vs-health-insurance\nNational Community Oncology Dispensing Association 2018 Spring Forum: www.ajmc.com/conferences/ncoda-spring-forum-2018\nPembrolizumab Granted Priority Review for Treatment of Cervical Cancer: www.ajmc.com/newsroom/pembrolizumab-granted-priority-review-for-treatment-of-cervical-cancer\nAssociation of Community Cancer Centers' 44th annual meeting: www.ajmc.com/conferences/accc-2018